The Indian Journal of Pediatrics

, Volume 67, Issue 12, pp 915–921

Neural tube defects : Prevention by folic acid and other vitamins

Symposium: Genetics for Pediatricians-II

Abstract

Folic acid has been demonstrated in clinical trials to reduce significantly the recurrence (and probably occurrence) of neural tube defects (NTD). In the U.K., there has been no decline in prevalence of NTD since the publication of the findings with folic acid. This article examines a series of questions relating to the action of folic acid, with emphasis on the use of mouse models as a source of experimental information which cannot easily be obtained by direct study of humans. Several mouse genetic NTD models exhibit sensitivity to prevention by folic acid, whereas other mice which develop morphologically similar NTD are resistant. Folic acid normalises neurulation in the sensitive mouse strains, providing evidence for a direct effect on the developing embryo, not on the pregnant female. Mouse studies do not support the proposed action of folic acid in encouraging thein utero demise of affected fetuses (i.e. terathanasia). Polymorphic variants of several folate-related enzymes have been shown to influence risk of NTD in humans and an inherited abnormality of folate metabolism has been demonstrated in one mouse NTD model. However, the biochemical basis of the action of folic acid in preventing NTD remains to be determined in detail. NTD in one folate-resistant mouse strain can be prevented by myoinositol, bothin utero andin vitro, raising the possibility of a therapeutic role also in humans. Gene-gene interactions seem likely to underlie the majority of NTD, suggesting that poly-therapy involving folic acid and other agents, such as myo-inositol, may prove more effective in preventing NTD than folic acid treatment alone.

Keywords

Neural tube defects Folic acid Mouse models Inositol Prevention 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Copp AJ, Bernfield M. Etiology and pathogenesis of human neural tube defects: Insights from mouse models.Curr Opin Pediatr 1994; 6: 624–631.PubMedCrossRefGoogle Scholar
  2. 2.
    Harding BN, Copp AJ. Congenital malformations. In: Graham Dl, Lantos PL, eds.Greenfield’s Neuropathology. 6th ed. London:Arnold; 1997; 397–533.Google Scholar
  3. 3.
    Copp AJ. Genetic models of mammalian neural tube defects. In: Bock G, Marsh J, eds.Neural Tube Defects (Ciba Foundation Symposium 181). Chichester: John Wiley & Sons; 1994; pp. 118–134.Google Scholar
  4. 4.
    Brock DJH, Sutcliffe RG. Early prenatal diagnosis of anencephaly.Lancet 1972; 2:1252–1253.PubMedCrossRefGoogle Scholar
  5. 5.
    Nicolaides KH, Gabbe SG, Campbell S, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs.Lancet 1986; 2: 72–74.PubMedCrossRefGoogle Scholar
  6. 6.
    Smithells RW, Sheppard S, Schorah CJ, Seller MJ, NevinNC, Harris R, Read AP. Fielding DW. Apparent prevention of neural tube defects by periconceptional vitamin supplementation.Arch Dis Child 1981; 56:911–918.PubMedGoogle Scholar
  7. 7.
    Wald N, Sneddon J, Densem J, Frost C, Stone R, MRC Vitamin Study Res Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study.Lancet 1991; 338:131–137.CrossRefGoogle Scholar
  8. 8.
    Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.N Engl J Med 1992; 327:1832–1835.PubMedCrossRefGoogle Scholar
  9. 9.
    Scott JM, Kirke PN, Weir DG. The role of nutrition in neural tube defects. Annu Rev Nutr 1990;10: 277–295.PubMedCrossRefGoogle Scholar
  10. 10.
    Abramsky L, Botting B, Chappie J, Stone D. Has advice on periconceptional folate supplementation reduced neural-tube defects?Lancet 1999; 354:998–999.PubMedCrossRefGoogle Scholar
  11. 11.
    Juriloff DM, Harris MJ. Mouse models for neural tube closure defects.Hum Mol Genet 2000; 9: 993–1000.PubMedCrossRefGoogle Scholar
  12. 12.
    Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects?Lancet 1997; 350: 513–515.PubMedCrossRefGoogle Scholar
  13. 13.
    Zhao Q, Behringer RR, De Crombrugghe B. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for theCartl homeobox gene.Nature Genet 1996; 13: 275–283.PubMedCrossRefGoogle Scholar
  14. 14.
    Carter M, Ulrich S, Oofuji Y, Williams DA, Ross ME.Crooked tail (Cd) models human folate-responsive neural tube defects.Hum Mol Genet 1999; 8: 2199–2204.PubMedCrossRefGoogle Scholar
  15. 15.
    Fleming A, Copp AJ. Embryonic folate metabolism and mouse neural tube defects. Science 1998; 280:2107–2109.PubMedCrossRefGoogle Scholar
  16. 16.
    Scott JM, Weir DG, Molloy Aet al. Folk acid metabolism and mechanisms of neural tube defects. In: Bock G, Marsh J, ed.Neural Tube Defects (Ciba Foundation Symposium 181). Chichester:John Wiley & Sons; 1994; 180–187.Google Scholar
  17. 17.
    Heid MK, Bills ND, Hinrichs SH, Clifford AJ. Folate deficiency alone does not produce neural tube defects in mice.J Nutr 1992; 122: 888–894.PubMedGoogle Scholar
  18. 18.
    Cockroft DL. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture.Teratology 1988; 38: 281–290.PubMedCrossRefGoogle Scholar
  19. 19.
    Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, ScottJM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects.Q J Med 1993; 86:703–708.PubMedGoogle Scholar
  20. 20.
    Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Eskes TKAB. Neural-tube defects and dearangement of homocysteine metabolism.N Engl J Med 1991; 324:199–200.PubMedCrossRefGoogle Scholar
  21. 21.
    Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neural-tube defects.Lancet 1995; 345:149–151.PubMedCrossRefGoogle Scholar
  22. 22.
    Morrison K, Edwards YH, Lynch SA, Burn J, Hoi F, Mariman E. Methionine synthase and neural tube defects.J Med Genet 1997; 34: 958PubMedCrossRefGoogle Scholar
  23. 23.
    Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van den Heuvel LP, MarimanECM, Den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spinabifida.lancet 1995; 346:1070–1071.PubMedCrossRefGoogle Scholar
  24. 24.
    Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects.Q J Med 1995; 88: 763–766.Google Scholar
  25. 25.
    Wilson A, Platt R, Wu Q, Lederc D, Christensen B, YangH, Gravel RA, Rozen R. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12 @#@) increases risk for spina bifida.Mol Genet Metab 1999; 67: 317–323.PubMedCrossRefGoogle Scholar
  26. 26.
    Seller MJ. Vitamins, folic acid and the cause and prevention of neural tube defects. In: Bock G, Marsh J, eds.Neural Tube Defects (Ciba Foundation Symposium 181). Chichester. John Wiley & Sons; 1994; 161–173.Google Scholar
  27. 27.
    Greene NDE, Copp AJ. Inositol prevents folate-resistant neural tube defects in the mouse.Nature Med 1997; 3: 60–66.PubMedCrossRefGoogle Scholar
  28. 28.
    Cockroft DL, Brook FA, Copp AJ. Inositol deficiency increases the susceptibility to neural tube defects of genetically predisposed (curly tail) mouse embryos in vitro.Teratology 1992; 45: 223–232.PubMedCrossRefGoogle Scholar
  29. 29.
    Estibeiro JP, Brook FA, Copp AJ. Interaction betweensplotch (Sp) andcurly tail (ct) mouse mutants in the embryonic development of neural tube defects.Development 1993; 119:113–321.PubMedGoogle Scholar
  30. 30.
    Essien FB, Wannberg SL. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects inAxd mutant mice.J Nutr 1993; 123: 27–34.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2000

Authors and Affiliations

  1. 1.Neural Development Unit, Institute of Child HealthUniversity College, LondonLondon

Personalised recommendations